PTEN and melanoma: We herein demonstrated that migration ability was increased by the combination of BRAFV600E with the loss of Pten, but not by GNA11Q209L with the loss of Pten or by the lack of oncogenes with the loss of Pten, using our established cells and melanoma cell lines.